# Depakote-ER for Depressive and Bipolar Depression

> **NCT00226343** · PHASE4 · COMPLETED · sponsor: **Cambridge Health Alliance** · enrollment: 25 (—)

## Conditions studied

- Bipolar Disorder

## Interventions

- **DRUG:** Depakote-ER

## Key facts

- **NCT ID:** NCT00226343
- **Lead sponsor:** Cambridge Health Alliance
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2003-08
- **Primary completion:** 2006-01
- **Final completion:** 2006-08
- **Target enrollment:** 25 (—)
- **Last updated:** 2017-04-18

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00226343

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00226343, "Depakote-ER for Depressive and Bipolar Depression". Retrieved via AI Analytics 2026-07-01 from https://api.ai-analytics.org/clinical/NCT00226343. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*